Jun Zhou

1 clinical trials · Sponsor

Record	Firm	Date
Phase I, Open-labeled, Dose-escalation, Dose-expansion Study Evaluating the Safety, Tolerance, Pharmacokinetics, and Activity of IUAb190708 in Patients With Advanced or Recurrent Solid Tumors (NCT07584954)	Jun Zhou	2024-06-18

Every clearance here is in the API, with alerts when new ones post.